erythrosine has been researched along with ono 1078 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houzawa, S; Kurose, I; Miura, S; Nagata, H; Serizawa, H; Suematsu, M; Suzuki, M; Tanaka, S; Tsuchiya, M | 1 |
Fukuda, M; Kawabata, S; Kohno, S; Nakamura, T; Nakano, R; Noguchi, Y; Oka, M; Soda, H; Terashi, K; Tsukamoto, K | 1 |
2 other study(ies) available for erythrosine and ono 1078
Article | Year |
---|---|
Microcirculatory disturbance in indomethacin-induced intestinal ulcer.
Topics: Animals; Benzoquinones; Chromones; Fluorescein-5-isothiocyanate; Fluoresceins; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Leukocyte Count; Lipoxygenase Inhibitors; Male; Microcirculation; Neutrophils; Peroxidase; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; SRS-A; Ulcer | 1991 |
A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein.
Topics: Adenocarcinoma; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Chromones; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Leukotriene Antagonists; Leukotriene C4; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured; Vincristine | 1998 |